Friday
Apr132012
BioSmart Brief: Highlights NeoStem's PreSERVE Trial $NBS
PreSERVE-AMI tests autologous stem cell treatment for heart attack
Doctors at Orlando Health have started a trial as part of the nationwide PreSERVE-AMI study of pelvic bone marrow stem cells in treating tissue damage after a heart attack. The study of autologous transplant will involve 160 patients at 34 sites. American City Business Journals/Orlando, Fla.
tagged
nbs |
Print Article
Email Article Posted on
Friday, April 13, 2012 at 10:48AM
Permalink in
Regenerative Medicine






Reader Comments